Ra Capital Management, L.P. Catalyst Biosciences, Inc. Transaction History

Ra Capital Management, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2018 Aug 14, 2018	SELL	$9.11 - $28.88 $4.69 Million - $14.9 Million	-514,917 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$14.18 - $35.6 $7.3 Million - $18.3 Million	514,917 New	514,917 $13.3 Million

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.